Search results for: Health Policy and Regulation
Filter search results
Professor Graham Cookson Appointed OHE Director Designate
24 April 2018
…of Economic & Public Policy and Head of the Department of Health Care Management & Policy at University of Surrey. There he won major health research grants from the EU…
Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value
1 March 2017
…costs. The 2016 ICER Policy Summit convened an influential group of evidence policy leaders from insurers, pharmacy benefit management firms, and life science companies to discuss gene therapies and to…
Recommendations for Making Outcome-based Payments a Reality in the NHS: An Application to Cancer Drugs
21 February 2019
Making Outcome-based payments a reality in the NHS authored by The Office of Health Economics, RAND Europe, King’s College London, and Cancer Research UK, and commissioned by Cancer Research UK…
Politics of Prescribing
1 January 1985
…of the seven most successful countries in the world in its record of pharmaceutical innovation. The other six are the United States, West Germany, Switzerland, France, Italy and Japan. No…
Indication-Based Pricing: Are We All Onboard?
12 May 2020
…https://www.ohe.org/publications/multi-indication-pricing-mip-practical-solutions-and-steps-move-forward# Mestre-Ferrandiz,J., Towse, A., Dellamano, R., and Pistollato, M. (2015). Multi-indication Pricing: Pros, Cons and Applicability to the UK. Seminar Briefing 56. Office of Health Economics. Available at: https://www.ohe.org/publications/multi-indication-pricing-pros-cons-and-applicability-uk …
Virtual OHE Annual Lecture 2021: Do Patents Work? Evidence from Pharmaceutical Innovation
14 October 2021, 1:00pm
…and academic spillovers in R&D productivity, firm-specific and policy determinants of the distribution of new products, and competition from generic drugs. Professor Kyle has examined the impact of trade and…
2019 OHE Annual Report to the Charity Commission
1 December 2020
…advancing the education of the public in general/health care payers/policy makers on the subject of health economics and health care policy; and using health economics methods to produce evidence-based health…
Surveillance and Early Diagnosis and General Practice
1 July 1966
…stage which early diagnosis and screening, for example in diabetes and glaucoma, had reached in this country. To supplement this, Professor Jungner and Dr Collen were asked to describe briefly…
Valuing Health at the End of Life: A Stated Preference Discrete Choice Experiment
1 December 2012
…of life policy require amending, and in fact call into question whether such a policy of giving higher priority to end of life treatments than to other types of treatments…